Relapsed Acute Myeloid Leukemia With Isolated Conjugated Hyperbilirubinemia Secondary to High-Dose Cytarabine Therapy

被引：0
|
作者：
Akpara, Ugochukwu [1 ]
Choi, Anthony J. [2 ]
Wan, David [3 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, Brooklyn, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S2562
引用
收藏
页码：S1348 / S1348
页数：1
相关论文
共 50 条
  • [21] Cytarabine in relapsed acute myeloid leukemia
    Hardesty, Brandon M.
    Cripe, Larry D.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 387 - 388
  • [22] Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)
    Ulf Schnetzke
    Peter Fix
    Baerbel Spies-Weisshart
    Karin Schrenk
    Anita Glaser
    Hans-Joerg Fricke
    Paul La Rosée
    Andreas Hochhaus
    Sebastian Scholl
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1391 - 1397
  • [23] Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)
    Schnetzke, Ulf
    Fix, Peter
    Spies-Weisshart, Baerbel
    Schrenk, Karin
    Glaser, Anita
    Fricke, Hans-Joerg
    La Rosee, Paul
    Hochhaus, Andreas
    Scholl, Sebastian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (08) : 1391 - 1397
  • [24] HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA
    LOCKHART, S
    PLUNKETT, W
    JEHA, S
    RAMIREZ, I
    ZIPF, T
    CORK, A
    PINKEL, D
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 587 - 595
  • [25] Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine
    Raanani, P
    Shpilberg, O
    Gillis, S
    Avigdor, A
    Hardan, I
    Berkowicz, M
    Sofer, O
    Lossos, I
    Chetrit, A
    Ben-Yehuda, D
    Bell-Bassat, I
    LEUKEMIA RESEARCH, 1999, 23 (08) : 695 - 700
  • [26] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN REFRACTORY ADULT ACUTE MYELOID-LEUKEMIA
    HIDDEMANN, W
    KREUTZMANN, H
    LUDWIG, WD
    AUL, HC
    DONHUIJSENANT, R
    LENGFELDER, E
    BUCHNER, T
    LANCET, 1985, 2 (8453): : 508 - 509
  • [27] High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations
    不详
    Nature Clinical Practice Oncology, 2009, 6 (1): : 3 - 4
  • [28] High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemiais more better or more of the same?
    Wolach, Ofir
    Itchaki, Gilad
    Bar-Natan, Michal
    Yeshurun, Moshe
    Ram, Ron
    Herscovici, Corina
    Shpilberg, Ofer
    Douer, Dan
    Tallman, Martin S.
    Raanani, Pia
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (01) : 28 - 35
  • [29] Results of high-dose cytarabine consolidation and interferon alpha maintenance therapy in acute myeloid leukemia (AML)
    Saikia, TK
    Advani, SH
    Gopal, R
    Nair, CN
    Sawant, VS
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 226 - 226
  • [30] HIGH-DOSE CYTARABINE IN ACUTE MYELOGENOUS LEUKEMIA
    ZITTOUN, R
    BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 42
12345